• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HSO
Click for more information
0.00% $2.43

HEALTHSCOPE LIMITED. - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HSO Becoming a substantial holder26/03/19
HSO Change in substantial holding25/03/19
HSO Change in substantial holding25/03/19
HSO Ceasing to be a substantial holder25/03/19
HSO Change in substantial holding from NAB22/03/19
HSO Becoming a substantial holder22/03/19
HSO Change in substantial holding21/03/19
HSO FIRB Approval received for Brookfield transactionPRICE SENSITIVE19/03/19
HSO Change in substantial holding19/03/19
HSO Change in substantial holding19/03/19
HSO Becoming a substantial holder from NAB18/03/19
HSO Change in substantial holding15/03/19
HSO Revised notice of initial substantial holder01/03/19
HSO Ceasing to be a substantial holder01/03/19
HSO Ceasing to be a substantial holder28/02/19
HSO Becoming a substantial holder22/02/19
HSO Ceasing to be a substantial holder19/02/19
HSO FY19 Half Year Results PresentationPRICE SENSITIVE14/02/19
HSO FY19 Half Year Results ReleasePRICE SENSITIVE14/02/19
HSO Half Yearly Report and AccountsPRICE SENSITIVE14/02/19
HSO Dividend/Distribution - HSOPRICE SENSITIVE14/02/19
HSO Ceasing to be a substantial holder from NAB13/02/19
HSO Becoming a substantial holder12/02/19
HSO 1HFY19 Financial results - scheduled release date08/02/19
HSO Becoming a substantial holder07/02/19
HSO Ceasing to be a substantial holder06/02/19
HSO Becoming a substantial holder06/02/19
HSO Change in substantial holding05/02/19
HSO Becoming a substantial holder04/02/19
HSO Becoming a substantial holder from NAB04/02/19
HSO Ceasing to be a substantial holder04/02/19
HSO Becoming a substantial holder04/02/19
HSO Change in substantial holding confirmation statementPRICE SENSITIVE01/02/19
HSO Update on BGH-Australiansuper consortium proposalPRICE SENSITIVE01/02/19
HSO Healthscope enters into Implementation Deed with BrookfieldPRICE SENSITIVE01/02/19
HSO Update on 1HFY19 Trading PerformancePRICE SENSITIVE01/02/19
HSO Update on Brookfield ProposalPRICE SENSITIVE21/01/19
HSO Ceasing to be a substantial holder21/01/19
HSO Ceasing to be a substantial holder from NAB10/01/19
HSO Update on BGH- AustralianSuper Consortium ProposalPRICE SENSITIVE21/12/18
HSO Update on Brookfield ProposalPRICE SENSITIVE21/12/18
HSO Pause in TradingPRICE SENSITIVE21/12/18
HSO Becoming a substantial holder from NAB11/12/18
HSO Change in substantial holding07/12/18
HSO Change in substantial holding05/12/18
HSO Change in substantial holding04/12/18
HSO Healthscope repays Project Finance Debt Facility04/12/18
HSO Change in substantial holding28/11/18
HSO Becoming a substantial holder22/11/18
HSO Change of Director's Interest Notice21/11/18
HSO Change in substantial holding20/11/18
HSO Update on Brookfield Proposal - exclusivity periodPRICE SENSITIVE19/11/18
HSO Becoming a substantial holder19/11/18
HSO Appendix 3B15/11/18
HSO Ceasing to be a substantial holder15/11/18
HSO Healthscope announces proposal from BrookfieldPRICE SENSITIVE12/11/18
HSO BGH Consortium - cash settled equity swap and Form 604PRICE SENSITIVE09/11/18
HSO Ceasing to be a substantial holder from MQG07/11/18
HSO Becoming a substantial holder from MQG02/11/18
HSO Becoming a substantial holder31/10/18
HSO Results of Meeting31/10/18
HSO MD & CEO's Address to ShareholdersPRICE SENSITIVE31/10/18
HSO Chairman's AGM Address to ShareholdersPRICE SENSITIVE31/10/18
HSO Update on 1QFY19 tradingPRICE SENSITIVE31/10/18
HSO BGH Consortium increases interest in HealthscopePRICE SENSITIVE31/10/18
HSO BGH Consortium cash settled equity swapPRICE SENSITIVE30/10/18
HSO Update on unsolicited and conditional acquisition proposalPRICE SENSITIVE30/10/18
HSO Healthscope Opens Northern Beaches Hospital30/10/18
HSO Ceasing to be a substantial holder26/10/18
HSO BGH Consortium cash settled equity swap and Form 604PRICE SENSITIVE25/10/18
HSO Healthscope to Open Northern Beaches Hospital 30 Oct 201824/10/18
HSO Appendix 3B23/10/18
HSO Supplementary Information relating to FY18 KMP STI Awards23/10/18
HSO Unsolicited and Conditional Acquisition ProposalPRICE SENSITIVE23/10/18
HSO Becoming a substantial holder16/10/18
HSO Change of Director's Interest Notice05/10/18
HSO Change of Director's Interest Notice05/10/18
HSO Change of Director's Interest Notice05/10/18
HSO Appendix 3B28/09/18
HSO 2018 Sustainability Report27/09/18
HSO Proxy Form27/09/18
HSO Chairman's Letter27/09/18
HSO Notice of Annual Meeting27/09/18
HSO Dividend Reinvestment Plan (DRP) - DRP Price27/09/18
HSO Ceasing to be a substantial holder26/09/18
HSO Change of Director's Interest Notice05/09/18
HSO Tax transparency statement21/08/18
HSO Dividend/Distribution - HSO21/08/18
HSO FY18 results presentationPRICE SENSITIVE21/08/18
HSO Appendix 4G key to corporate governance disclosures21/08/18
HSO Corporate Governance Statement21/08/18
HSO Appendix 4E, FY18 media release and Annual ReportPRICE SENSITIVE21/08/18
HSO Outcome of Strategic Review of Hospital Property AssetsPRICE SENSITIVE21/08/18
HSO Policy for Dealing in Securities - Updates20/08/18
HSO Healthscope completes sale of Asian Pathology17/08/18
HSO Key dates for 2018 Full Year Results08/08/18
HSO Healthscope announces sale of Asian Pathology to TPGPRICE SENSITIVE30/07/18
HSO Becoming a substantial holder10/07/18
HSO Appendix 3B29/06/18
HSO Update on acquisition proposals & property strategic reviewPRICE SENSITIVE22/05/18
HSO Becoming a substantial holder
26/03/19
HSO Change in substantial holding
25/03/19
HSO Change in substantial holding
25/03/19
HSO Ceasing to be a substantial holder
25/03/19
HSO Change in substantial holding from NAB
22/03/19
HSO Becoming a substantial holder
22/03/19
HSO Change in substantial holding
21/03/19
HSO FIRB Approval received for Brookfield transaction
19/03/19PRICE SENSITIVE
HSO Change in substantial holding
19/03/19
HSO Change in substantial holding
19/03/19
HSO Becoming a substantial holder from NAB
18/03/19
HSO Change in substantial holding
15/03/19
HSO Revised notice of initial substantial holder
01/03/19
HSO Ceasing to be a substantial holder
01/03/19
HSO Ceasing to be a substantial holder
28/02/19
HSO Becoming a substantial holder
22/02/19
HSO Ceasing to be a substantial holder
19/02/19
HSO FY19 Half Year Results Presentation
14/02/19PRICE SENSITIVE
HSO FY19 Half Year Results Release
14/02/19PRICE SENSITIVE
HSO Half Yearly Report and Accounts
14/02/19PRICE SENSITIVE
HSO Dividend/Distribution - HSO
14/02/19PRICE SENSITIVE
HSO Ceasing to be a substantial holder from NAB
13/02/19
HSO Becoming a substantial holder
12/02/19
HSO 1HFY19 Financial results - scheduled release date
08/02/19
HSO Becoming a substantial holder
07/02/19
HSO Ceasing to be a substantial holder
06/02/19
HSO Becoming a substantial holder
06/02/19
HSO Change in substantial holding
05/02/19
HSO Becoming a substantial holder
04/02/19
HSO Becoming a substantial holder from NAB
04/02/19
HSO Ceasing to be a substantial holder
04/02/19
HSO Becoming a substantial holder
04/02/19
HSO Change in substantial holding confirmation statement
01/02/19PRICE SENSITIVE
HSO Update on BGH-Australiansuper consortium proposal
01/02/19PRICE SENSITIVE
HSO Healthscope enters into Implementation Deed with Brookfield
01/02/19PRICE SENSITIVE
HSO Update on 1HFY19 Trading Performance
01/02/19PRICE SENSITIVE
HSO Update on Brookfield Proposal
21/01/19PRICE SENSITIVE
HSO Ceasing to be a substantial holder
21/01/19
HSO Ceasing to be a substantial holder from NAB
10/01/19
HSO Update on BGH- AustralianSuper Consortium Proposal
21/12/18PRICE SENSITIVE
HSO Update on Brookfield Proposal
21/12/18PRICE SENSITIVE
HSO Pause in Trading
21/12/18PRICE SENSITIVE
HSO Becoming a substantial holder from NAB
11/12/18
HSO Change in substantial holding
07/12/18
HSO Change in substantial holding
05/12/18
HSO Change in substantial holding
04/12/18
HSO Healthscope repays Project Finance Debt Facility
04/12/18
HSO Change in substantial holding
28/11/18
HSO Becoming a substantial holder
22/11/18
HSO Change of Director's Interest Notice
21/11/18
HSO Change in substantial holding
20/11/18
HSO Update on Brookfield Proposal - exclusivity period
19/11/18PRICE SENSITIVE
HSO Becoming a substantial holder
19/11/18
HSO Appendix 3B
15/11/18
HSO Ceasing to be a substantial holder
15/11/18
HSO Healthscope announces proposal from Brookfield
12/11/18PRICE SENSITIVE
HSO BGH Consortium - cash settled equity swap and Form 604
09/11/18PRICE SENSITIVE
HSO Ceasing to be a substantial holder from MQG
07/11/18
HSO Becoming a substantial holder from MQG
02/11/18
HSO Becoming a substantial holder
31/10/18
HSO Results of Meeting
31/10/18
HSO MD & CEO's Address to Shareholders
31/10/18PRICE SENSITIVE
HSO Chairman's AGM Address to Shareholders
31/10/18PRICE SENSITIVE
HSO Update on 1QFY19 trading
31/10/18PRICE SENSITIVE
HSO BGH Consortium increases interest in Healthscope
31/10/18PRICE SENSITIVE
HSO BGH Consortium cash settled equity swap
30/10/18PRICE SENSITIVE
HSO Update on unsolicited and conditional acquisition proposal
30/10/18PRICE SENSITIVE
HSO Healthscope Opens Northern Beaches Hospital
30/10/18
HSO Ceasing to be a substantial holder
26/10/18
HSO BGH Consortium cash settled equity swap and Form 604
25/10/18PRICE SENSITIVE
HSO Healthscope to Open Northern Beaches Hospital 30 Oct 2018
24/10/18
HSO Appendix 3B
23/10/18
HSO Supplementary Information relating to FY18 KMP STI Awards
23/10/18
HSO Unsolicited and Conditional Acquisition Proposal
23/10/18PRICE SENSITIVE
HSO Becoming a substantial holder
16/10/18
HSO Change of Director's Interest Notice
05/10/18
HSO Change of Director's Interest Notice
05/10/18
HSO Change of Director's Interest Notice
05/10/18
HSO Appendix 3B
28/09/18
HSO 2018 Sustainability Report
27/09/18
HSO Proxy Form
27/09/18
HSO Chairman's Letter
27/09/18
HSO Notice of Annual Meeting
27/09/18
HSO Dividend Reinvestment Plan (DRP) - DRP Price
27/09/18
HSO Ceasing to be a substantial holder
26/09/18
HSO Change of Director's Interest Notice
05/09/18
HSO Tax transparency statement
21/08/18
HSO Dividend/Distribution - HSO
21/08/18
HSO FY18 results presentation
21/08/18PRICE SENSITIVE
HSO Appendix 4G key to corporate governance disclosures
21/08/18
HSO Corporate Governance Statement
21/08/18
HSO Appendix 4E, FY18 media release and Annual Report
21/08/18PRICE SENSITIVE
HSO Outcome of Strategic Review of Hospital Property Assets
21/08/18PRICE SENSITIVE
HSO Policy for Dealing in Securities - Updates
20/08/18
HSO Healthscope completes sale of Asian Pathology
17/08/18
HSO Key dates for 2018 Full Year Results
08/08/18
HSO Healthscope announces sale of Asian Pathology to TPG
30/07/18PRICE SENSITIVE
HSO Becoming a substantial holder
10/07/18
HSO Appendix 3B
29/06/18
HSO Update on acquisition proposals & property strategic review
22/05/18PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.